These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36072585)

  • 1. Aberrant signaling of immune cells in Sjögren's syndrome patient subgroups upon interferon stimulation.
    Sarkar I; Davies R; Aarebrot AK; Solberg SM; Petrovic A; Joshi AM; Bergum B; Brun JG; Hammenfors D; Jonsson R; Appel S
    Front Immunol; 2022; 13():854183. PubMed ID: 36072585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature.
    Davies R; Hammenfors D; Bergum B; Vogelsang P; Gavasso S; Brun JG; Jonsson R; Appel S
    Eur J Immunol; 2018 Jul; 48(7):1217-1227. PubMed ID: 29604049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
    Davies R; Sarkar I; Hammenfors D; Bergum B; Vogelsang P; Solberg SM; Gavasso S; Brun JG; Jonsson R; Appel S
    Front Immunol; 2019; 10():281. PubMed ID: 30846988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets.
    Ritter J; Szelinski F; Aue A; Stefanski AL; Rincon-Arevalo H; Chen Y; Nitschke E; Dang VD; Wiedemann A; Schrezenmeier E; Lino AC; Dörner T
    J Autoimmun; 2024 Jul; 147():103243. PubMed ID: 38788537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.
    Hu P; Cai J; Yang C; Xu L; Ma S; Song H; Yang P
    Int Immunopharmacol; 2024 Jan; 126():111282. PubMed ID: 38061117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of CD8
    Li H; Zhou Y; Wang P; Wang Y; Feng Y; Zhang Y; Wu Z
    Clin Rheumatol; 2023 May; 42(5):1327-1338. PubMed ID: 36609932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
    Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
    Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren's disease.
    Gupta S; Yamada E; Nakamura H; Perez P; Pranzatelli TJ; Dominick K; Jang SI; Abed M; Martin D; Burbelo P; Zheng C; French B; Alevizos I; Khavandgar Z; Beach M; Pelayo E; Walitt B; Hasni S; Kaplan MJ; Tandon M; Magone MT; Kleiner DE; Chiorini JA; Baer A; Warner BM
    Ann Rheum Dis; 2024 Jul; 83(8):1034-1047. PubMed ID: 38527764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
    Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
    Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype.
    Huijser E; van Helden-Meeuwsen CG; Grashof DGB; Tarn JR; Brkic Z; Huisman JMA; Wahadat MJ; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Kamphuis S; Ng WF; Bekkering S; Joosten LAB; Dik WA; Versnel MA
    Front Immunol; 2022; 13():840751. PubMed ID: 35860283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
    Pertovaara M; Silvennoinen O; Isomäki P
    Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-dihydroxyvitamin D3 regulates t helper and b lymphocyte responses substantially in drug-naive primary Sjögren’s syndrome patients’ mononuclear cells.
    Genç D; Sezer Kürkçü M; Günaydın B; Tarhan EF
    Turk J Med Sci; 2021 Oct; 51(5):2467-2476. PubMed ID: 34118806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
    Huijser E; Bodewes ILA; Lourens MS; van Helden-Meeuwsen CG; van den Bosch TPP; Grashof DGB; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Brkic Z; Dik WA; Versnel MA
    Rheumatology (Oxford); 2022 Aug; 61(8):3491-3496. PubMed ID: 35022662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
    Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the role of cDC2s in Sjögren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity.
    Lopes AP; Hillen MR; Hinrichs AC; Blokland SL; Bekker CP; Pandit A; Kruize AA; Radstake TR; van Roon JA
    Ann Rheum Dis; 2023 Mar; 82(3):374-383. PubMed ID: 36171070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal Single-Cell Sequencing of B Cells in Primary Sjögren's Syndrome.
    Arvidsson G; Czarnewski P; Johansson A; Raine A; Imgenberg-Kreuz J; Nordlund J; Nordmark G; Syvänen AC
    Arthritis Rheumatol; 2024 Feb; 76(2):255-267. PubMed ID: 37610265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
    Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
    Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Interferons in the Pathogenesis of Sjögren's Syndrome and Future Therapeutic Perspectives.
    Del Papa N; Minniti A; Lorini M; Carbonelli V; Maglione W; Pignataro F; Montano N; Caporali R; Vitali C
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.